1,269 results match your criteria: "Center for Applied Medical Research[Affiliation]"

Sucralose uses reward pathways to promote acute caloric intake.

Neuropeptides

January 2025

The Dr. John and Anne Chong Laboratory for Functional Genomics, Charles Perkins Centre and School of Life & Environmental Sciences, The University of Sydney, Sydney, NSW 2006, Australia. Electronic address:

Non-nutritive sweeteners (NNSs) are used to reduce caloric intake by replacing sugar with compounds that are sweet but contain little or no calories. In this study, we investigate how non-nutritive sweetener sucralose to promote acute food intake in the fruit fly Drosophila melanogaster. Our results showed that acute exposure to NNSs sweetness induces a robust hyperphagic response in flies.

View Article and Find Full Text PDF

Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma.

N Engl J Med

January 2025

From Tel Aviv Sourasky Medical Center (Y.C.C., I.A.), and the Faculty of Medical and Health Sciences, Tel Aviv University (Y.C.C., H.M., I.A.), Tel Aviv, Chaim Sheba Medical Center, Ramat Gan (H.M.), and Hadassah Hebrew University Medical Center, Jerusalem (M.G.) - all in Israel; McGill University and McGill University Health Centre, Montreal (M.S.), and Alberta Health Services, Edmonton (M.P.C.) - all in Canada; Samsung Medical Center, Sungkyunkwan University School of Medicine (K.K.), Seoul St. Mary's Hospital, Catholic University of Korea (C.-K.M.), and Seoul National University College of Medicine (S.-S.Y.) - all in Seoul, South Korea; Hospital Universitario Marqués de Valdecilla, Instituto de Investigación Sanitaria Valdecilla, Universidad de Cantabria, Santander (E.M.O.), Cancer Center Clínica Universidad de Navarra, Center for Applied Medical Research, Pamplona (P.R.-O.), Institut Català d'Oncologia, Josep Carreras Leukemia Research Institute, and the Hospital Germans Trias i Pujol, Barcelona (A.O.), START Madrid-Fundación Jiménez Díaz Early Phase Unit, University Hospital Fundación Jiménez Díaz, Madrid (D.M.), and the University Hospital of Salamanca, Institute for Biomedical Research of Salamanca, the Salamanca Cancer Research Center, and Centro de Investígación Biomédica en Red Cáncer, Salamanca (M.-V.M.) - all in Spain; Janssen Research and Development, Spring House, PA (N.A.Q.C., A.K., M.K., M.R.P., E.S., B.H., J.V., A.B.); and Janssen Research and Development, Allschwil, Switzerland (L.D.S.).

Background: Talquetamab (anti-G protein-coupled receptor family C group 5 member D) and teclistamab (anti-B-cell maturation antigen) are bispecific antibodies that activate T cells by targeting CD3 and that have been approved for the treatment of triple-class-exposed relapsed or refractory multiple myeloma.

Methods: We conducted a phase 1b-2 study of talquetamab plus teclistamab in patients with relapsed or refractory multiple myeloma. In phase 1, we investigated five dose levels in a dose-escalation study.

View Article and Find Full Text PDF

Structural or electrophysiologic cardiac anomalies may compromise cardiac function, leading to sudden cardiac death (SCD). Genetic screening of families with severe cardiomyopathies underlines the role of genetic variations in cardiac-specific genes. The present study details the clinical and genetic characterization of a malignant dilated cardiomyopathy (DCM) case in a 1-year-old Mexican child who presented a severe left ventricular dilation and dysfunction that led to SCD.

View Article and Find Full Text PDF

Clear cell renal cell carcinoma (ccRCC) is one of the most challenging neoplasms because of its phenotypic variability and intratumoral heterogeneity. Because of its variability, ccRCC is a good test bench for the application of new technological approaches to unveiling its intricacies. Multiplex immunofluorescence (mIF) is an emerging method that enables the simultaneous and detailed assessment of tumor and stromal cell subpopulations in a single tissue section.

View Article and Find Full Text PDF

Functional Neuroanatomy of the Normal and Pathological Basal Ganglia.

Cold Spring Harb Perspect Med

December 2024

Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CiberNed-ISCIII), 28029 Madrid, Spain.

The term "basal ganglia" refers to a group of interconnected subcortical nuclei engaged in motor planning and movement initiation, executive functions, behaviors, and emotions. Dopamine released from the substantia nigra is the underlying driving force keeping the basal ganglia network under proper equilibrium and, indeed, reduction of dopamine levels triggers basal ganglia dysfunction, setting the groundwork for several movement disorders. The canonical basal ganglia model has been instrumental for most of our current understanding of the normal and pathological functioning of this subcortical network.

View Article and Find Full Text PDF

Neuroprotective Effects of Dexamethasone in a Neuromelanin-Driven Parkinson's Disease Model.

J Neuroimmune Pharmacol

December 2024

Gene Therapy for CNS Disorders Program, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.

Parkinson's disease (PD) is characterized by the progressive loss of dopaminergic neurons in the substantia nigra that primarily affects movement control. Neuroinflammation plays a pivotal role in driving the disease's progression. The persistent inflammatory state in the brain exacerbates neuronal damage, creating a cycle that perpetuates the neurodegenerative process.

View Article and Find Full Text PDF

The precise mechanisms by which the complement system contributes to the establishment of an immunosuppressive tumor microenvironment (TME) and promotes tumor progression remain unclear. In this study, we investigated the expression and function of complement C5a receptor 1 (C5aR1) in human and mouse cancer-associated dendritic cells (DCs). First, we observed an overexpression of C5aR1 in tumor-infiltrating DCs, compared to DCs from blood or spleen.

View Article and Find Full Text PDF

RANK drives structured intestinal epithelial expansion during pregnancy.

Nature

January 2025

Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter (VBC), Vienna, Austria.

Article Synopsis
  • - During pregnancy and lactation, mammals experience significant changes in their intestinal epithelium, leading to an increase in intestinal surface area through the expansion of villi.
  • - The RANK-RANKL molecular pathway is crucial for this process, protecting gut cells from death and promoting intestinal stem cell activity, which results in villous elongation.
  • - Mice lacking RANK in their intestinal epithelium have offspring that are heavier and more prone to glucose intolerance, highlighting the importance of RANK-RANKL in both immediate and long-term health outcomes for offspring.
View Article and Find Full Text PDF
Article Synopsis
  • Glypican-3 (GPC3) is a potential target for T-cell therapy in hepatocellular carcinoma (HCC), but current CAR T-cell approaches face issues like low persistence and GPC3 shedding.
  • Researchers immunized HLA-A2 transgenic mice to find GPC3-specific T-cell receptors (TCRs) and engineered human T cells (TCR-Ts) that effectively recognize GPC3-positive HCC cells.
  • TCR-B-T cells showed superior effectiveness compared to traditional CAR T-cells, and combining CAR-T and TCR-B-T cells may enhance therapeutic results in treating HCC.
View Article and Find Full Text PDF

Quantitative Approach to Explore Regulatory T Cell Activity in Immuno-Oncology.

Pharmaceutics

November 2024

Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain.

Article Synopsis
  • - The complexities of the tumor microenvironment (TME), particularly the role of regulatory T cells (Treg), complicate the effectiveness of cancer immunotherapies by allowing tumors to evade the immune system.
  • - Researchers are exploring methods to inhibit Treg, which are important for immune balance but can hinder cancer treatment when present in tumors, using mechanistic mathematical models to simulate and predict outcomes of various therapies.
  • - The review discusses various computational models that analyze Treg's impact on immunotherapy failure, highlights molecules associated with immune suppression in the TME, and presents potential new therapies targeting Treg for effective treatment combinations.
View Article and Find Full Text PDF

Ultra-low-pass whole-genome sequencing (ULP-WGS) (≤0.5× coverage) of plasma cell-free DNA (cfDNA) has emerged as a low-cost promising tool to assess circulating tumor DNA (ctDNA) fraction. This meta-analysis aims to summarize the current findings and comprehensively investigate the prognostic value of baseline ctDNA detected by ULP-WGS in solid tumors.

View Article and Find Full Text PDF

Uncovering functional lncRNAs by scRNA-seq with ELATUS.

Nat Commun

November 2024

Center for Applied Medical Research, University of Navarra, PIO XII 55 Ave, Pamplona, Spain.

Long non-coding RNAs (lncRNAs) play fundamental roles in cellular processes and pathologies, regulating gene expression at multiple levels. Despite being highly cell type-specific, their study at single-cell (sc) level is challenging due to their less accurate annotation and low expression compared to protein-coding genes. Here, we systematically benchmark different preprocessing methods and develop a computational framework, named ELATUS, based on the combination of the pseudoaligner Kallisto with selective functional filtering.

View Article and Find Full Text PDF
Article Synopsis
  • VCE-003.2, a derivative of cannabigerol, shows neuroprotective effects in Parkinson's disease models linked to mitochondrial dysfunction and neuroinflammation, now being tested against protein dysregulation associated with the disease.
  • Researchers administered an adeno-associated viral vector carrying a mutated α-synuclein gene to mice, causing motor impairments and neuron loss, then treated them with VCE-003.2 to assess its effects.
  • Results indicated that VCE-003.2 significantly improved motor performance, preserved neuron integrity, reduced microglia and astrocyte activation in the brain, and influenced gene expression related to immune responses, expanding its potential therapeutic benefits in Parkinson's disease.
View Article and Find Full Text PDF

Epithelial-to-mesenchymal transition (EMT) triggers cell plasticity in embryonic development, adult injured tissues and cancer. Combining the analysis of EMT in cell lines, embryonic neural crest and mouse models of renal fibrosis and breast cancer, we find that there is not a cancer-specific EMT program. Instead, cancer cells dedifferentiate and bifurcate into two distinct and segregated cellular trajectories after activating either embryonic-like or adult-like EMTs to drive dissemination or inflammation, respectively.

View Article and Find Full Text PDF

Sensitizing cholangiocarcinoma to chemotherapy by inhibition of the drug-export pump MRP3.

Biomed Pharmacother

November 2024

Experimental Hepatology and Drug Targeting (HEVEPHARM), University of Salamanca, Salamanca, Spain; Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Carlos III National Institute of Health, Madrid, Spain.

Aims: Drug export through ABC proteins hinders cancer response to chemotherapy. Here, we have evaluated the relevance of MRP3 (ABCC3) in cholangiocarcinoma (CCA) as a potential target to overcome drug resistance.

Methods: Gene expression was analyzed in silico using the TCGA-CHOL database and experimentally (mRNA and protein) in resected CCA tumors.

View Article and Find Full Text PDF
Article Synopsis
  • The text discusses the creation of gmctool, an online tool designed to predict metabolic weaknesses in cancer cells, which is important for systems biology research.
  • This tool utilizes a concept called genetic Minimal Cut Sets (gMCSs) to analyze genome-scale metabolic networks and includes a database of synthetic lethals derived from the latest metabolic map of human cells.
  • Notably, gmctool has shown improved performance over earlier algorithms and has been applied to multiple myeloma, a type of blood cancer, providing experimental evidence for the critical roles of specific enzymes in certain patient groups.
View Article and Find Full Text PDF

RNA-loaded nanoparticles for the treatment of hematological cancers.

Adv Drug Deliv Rev

November 2024

Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, Universidad de Navarra, C/Irunlarrea 1, 31008 Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra, IdiSNA, C/Irunlarrea 3, 31008 Pamplona, Spain; Cancer Center Clinica Universidad de Navarra (CCUN). Avenida Pio XII 36, 31008 Pamplona, Spain. Electronic address:

Hematological cancers encompass a diverse group of malignancies affecting the blood, bone marrow, lymph nodes, and spleen. These disorders present unique challenges due to their complex etiology and varied clinical manifestations. Despite significant advancements in understanding and treating hematological malignancies, innovative therapeutic approaches are continually sought to enhance patient outcomes.

View Article and Find Full Text PDF

The cellular prion protein (PrP) plays many roles in the developing and adult brain. In addition, PrP binds to several amyloids in oligomeric and prefibrillar forms and may act as a putative receptor of abnormal misfolded protein species. The role of PrP in tau seeding and spreading is not known.

View Article and Find Full Text PDF

Study of pediatric invasive pneumococcal disease in the 13-pneumococcal conjugated vaccine era.

Diagn Microbiol Infect Dis

December 2024

Microbiology Department, University and Polytechnic Hospital La Fe Valencia, Spain; Severe Infection Research Group, Health Research Institute Hospital La Fe Valencia, Spain.

Background: Invasive pneumococcal disease (IPD) remains a significant concern among children under 5, despite vaccination efforts. This study assessed IPD prevalence and associated risks in pediatric population.

Methods: An observational, retrospective, multicenter study in Comunidad Valenciana, Spain, of IPD cases in children under 13 from January 2012 to September 2022.

View Article and Find Full Text PDF

Corn snakes are emerging models for animal colouration studies. Here, we focus on the Terrazzo morph, whose skin pattern is characterized by stripes rather than blotches. Using genome mapping, we discover a disruptive mutation in the coding region of the Premelanosome protein (PMEL) gene.

View Article and Find Full Text PDF

Calbindin and Girk2/Aldh1a1 define resilient vs vulnerable dopaminergic neurons in a primate Parkinson's disease model.

NPJ Parkinsons Dis

September 2024

HM CINAC (Centro Integral de Neurociencias Abarca Campal), Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid, Spain.

The differential vulnerability of dopaminergic neurons of the substantia nigra pars compacta (SNc) is a critical and unresolved question in Parkinson´s disease. Studies in mice show diverse susceptibility of subpopulations of nigral dopaminergic neurons to various toxic agents. In the primate midbrain, the molecular phenotypes of dopaminergic neurons and their differential vulnerability are poorly characterized.

View Article and Find Full Text PDF

The kidney-skeletal muscle-heart axis in chronic kidney disease: implications for myokines.

Nephrol Dial Transplant

August 2024

Center for Applied Medical Research (CIMA), and School of Medicine, University of Navarra, Pamplona, Spain.

Myokines are signalling moieties released by the skeletal muscle in response to acute and/or chronic exercise, which exert their beneficial or detrimental effects through paracrine and/or autocrine pathways on the own muscle and through endocrine pathways in many other organs (e.g. the heart).

View Article and Find Full Text PDF